Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34408079)

  • 1. ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
    Koneru B; Farooqi A; Nguyen TH; Chen WH; Hindle A; Eslinger C; Makena MR; Burrow TA; Wilson J; Smith A; Pilla Reddy V; Cadogan E; Durant ST; Reynolds CP
    Sci Transl Med; 2021 Aug; 13(607):. PubMed ID: 34408079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.
    Macha SJ; Koneru B; Burrow TA; Zhu C; Savitski D; Rahman RL; Ronaghan CA; Nance J; McCoy K; Eslinger C; Reynolds CP
    Cancer Res; 2022 Sep; 82(18):3345-3358. PubMed ID: 35947641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
    Jones GN; Rooney C; Griffin N; Roudier M; Young LA; Garcia-Trinidad A; Hughes GD; Whiteaker JR; Wilson Z; Odedra R; Zhao L; Ivey RG; Howat WJ; Harrington EA; Barrett JC; Ramos-Montoya A; Lau A; Paulovich AG; Cadogan EB; Pierce AJ
    Br J Cancer; 2018 Nov; 119(10):1233-1243. PubMed ID: 30385821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
    George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
    J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
    Riches LC; Trinidad AG; Hughes G; Jones GN; Hughes AM; Thomason AG; Gavine P; Cui A; Ling S; Stott J; Clark R; Peel S; Gill P; Goodwin LM; Smith A; Pike KG; Barlaam B; Pass M; O'Connor MJ; Smith G; Cadogan EB
    Mol Cancer Ther; 2020 Jan; 19(1):13-25. PubMed ID: 31534013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
    Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
    Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
    Davis SL; Hartman SJ; Bagby SM; Schlaepfer M; Yacob BW; Tse T; Simmons DM; Diamond JR; Lieu CH; Leal AD; Cadogan EB; Hughes GD; Durant ST; Messersmith WA; Pitts TM
    BMC Cancer; 2022 Oct; 22(1):1107. PubMed ID: 36309653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
    Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
    Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres.
    Tong AS; Stern JL; Sfeir A; Kartawinata M; de Lange T; Zhu XD; Bryan TM
    Cell Rep; 2015 Nov; 13(8):1633-46. PubMed ID: 26586433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
    Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
    Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
    Goncalves T; Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Collopy LC; Strauss SJ; Mittnacht S; Tomita K
    ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1253-1264. PubMed ID: 33344901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
    Feldser D; Strong MA; Greider CW
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2249-51. PubMed ID: 16467146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
    Stohr BA; Blackburn EH
    Cancer Res; 2008 Jul; 68(13):5309-17. PubMed ID: 18593932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase.
    McNees CJ; Tejera AM; Martínez P; Murga M; Mulero F; Fernandez-Capetillo O; Blasco MA
    J Cell Biol; 2010 Mar; 188(5):639-52. PubMed ID: 20212315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal telomere maintenance in immortal ataxia telangiectasia cell lines.
    Sprung CN; Bryan TM; Reddel RR; Murnane JP
    Mutat Res; 1997 Oct; 379(2):177-84. PubMed ID: 9357546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
    Hu J; Hwang SS; Liesa M; Gan B; Sahin E; Jaskelioff M; Ding Z; Ying H; Boutin AT; Zhang H; Johnson S; Ivanova E; Kost-Alimova M; Protopopov A; Wang YA; Shirihai OS; Chin L; DePinho RA
    Cell; 2012 Feb; 148(4):651-63. PubMed ID: 22341440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arabidopsis ATM and ATR kinases prevent propagation of genome damage caused by telomere dysfunction.
    Amiard S; Depeiges A; Allain E; White CI; Gallego ME
    Plant Cell; 2011 Dec; 23(12):4254-65. PubMed ID: 22158468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.